Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Octapeptide neuromedin B antagonists described

July 26, 1996

Protein farnesyltransferase inhibitors described by Warner-Lambert

July 26, 1996

IL-2/interferon alpha/5-FU combination effective against metastatic renal cancer

July 26, 1996

Aphton announces commencement of phase III trials for Gastrimmune

July 26, 1996

O6-alkylguanine-DNA alkyltransferase inactivators disclosed

July 19, 1996

Suppressin from pituitary extract described by the University of Alabama

July 19, 1996

Cell-cell adhesion-regulating proteins as antitumor treatment

July 19, 1996

Potent selective protein farnesyltransferase inhibitor from Pierre Fabre

July 19, 1996

Clarion's CPR-1007 shows antitumor, antipsoriatic and antiinflammatory activity

July 19, 1996

Alfacell's Onconase warrants combination therapy studies

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...